GLS2 and hepatocellular carcinoma: To this end, we examined the expression of GLS1 and GLS2 in TMA (HLiv-HCC180Sur-01) with 90 paired NT and TT obtained from HCC patients, and analyzed the relationship between GLS1/GLS2 expression and patient survival.